Background. Integrated delivery systems (IDSs) are postulated to reduce spending and improve outcomes through successful coordination of care across multiple providers. Nonetheless, the actual impact of IDSs on outcomes for complex multidisciplinary care such as major cancer surgery is largely unknown. Methods. Using 2011-2013 Medicare data, this study identified patients who underwent surgical resection for prostate, bladder, esophageal, pancreatic, lung, liver, kidney, colorectal, or ovarian cancer. Rates of readmission, 30-day mortality, surgical complications, failure to rescue, and prolonged hospital stay for cancer surgery were compared between patients receiving care at IDS hospitals and those receiving care at non-IDS hospitals. Generalized estimating equations were used to adjust results by cancer type and patient-and hospital-level characteristics while accounting for clustering of patients within hospitals. Results. The study identified 380,053 patients who underwent major resection of cancer, with 38% receiving care at an IDS. Outcomes did not differ between IDS and non-IDS hospitals regarding readmission and surgical complication rates, whereas only minor differences were observed for 30-day mortality (3.5% vs 3.2% for IDS; p \ 0.001) and prolonged hospital stay (9.9% vs 9.2% for IDS; p \ 0.001). However, after adjustment for patient and hospital characteristics, the frequencies of adverse perioperative outcomes were not significantly associated with IDS status.
In recent years, increasing interest has been shown for health system integration as a means to improve quality and reduce costs associated with health care delivery. [1] [2] [3] Health care integration has many definitions, but generally is based on financial arrangements (e.g., a single entity manages multiple facilities or provider groups), functional connections (e.g., independent organizations with high levels of care coordination), or both 4 across an organization. Translated into clinical practice, integration is achieved with the end goal of successful coordination of patient care across the entire continuum of specialists, primary care providers, and health centers and services. 5 Although integrated delivery systems (IDSs) vary widely in size and degree of integration, these organizations generally have been associated with higher quality of care and outcomes for many conditions. [6] [7] [8] [9] Several explanations are proposed for these findings, including better care transition and handoffs to reduce complications and readmissions, reduction of duplicate tests and procedures, use of electronic medical records, and implementation of patient data and clinical guidelines within an integrated system. 10 Nonetheless, the actual impact of health system integration on outcomes is largely unknown for major cancer surgery and other types of complex, multidisciplinary care. It is plausible that an IDS will achieve better outcomes for these patients because these procedures often require coordinated efforts between multiple providers during and after the surgical episode. For instance, integration within a local delivery system may allow cancer patients to benefit from the shared resources maintained by a coordinated network of multi-specialty providers. 11 In addition, access to shared medical records and clinical data may improve care transitions and handoffs between providers that may lower rates of readmissions and prevent complications and patient mortality.
On the other hand, providers in a highly integrated system may not necessarily alter their practices to accommodate better inter-professional communication and care coordination. In this scenario, patient outcomes may not vary between integrated and non-integrated delivery systems.
Whereas the findings of previous investigators show that integrated delivery systems have improved coordination of care for primary care and outpatient visits, 6, 7, [12] [13] [14] [15] [16] the same effect has not been observed for surgical care or inpatient hospitalizations. 17 The current study built on this work by investigating the association between health system integration and outcomes for major cancer surgery. Specifically, we compared the rates of readmission, 30-day mortality, surgical complications, and prolonged hospital stay between patients receiving care at highly integrated and non-integrated hospitals for cancer resection surgery. By virtue of this approach, our findings will allow policymakers and hospital administrators to achieve better insight into the effect of hospital and health system integration on the quality of surgical oncology care.
METHODS

Data Sets
We used three data sets linked by hospital provider for our analysis. First, we used the 2011-2013 Medicare Provider Analysis and Review (MEDPAR) file to obtain our study cohort, patient demographic and clinical characteristics, and the perioperative outcomes of interest. Second, we used the American Hospital Association Annual Survey to measure hospital characteristics. Finally, we identified hospital IDS affiliation based on its listing among the top 100 integrated delivery systems ranked in Becker's Hospital Review, as described in previous work.
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Becker's Hospital Review identifies the top 100 IDSs by using strict selection criteria based on the financial, clinical, and operational strength of the health system, hospital and physician affiliations, and metrics from IMS Health. To assess the degree of integration, IMS Health uses the following eight major domains: overall integration, integrated technology (e.g., electronic medical records) use, hospital use, financial stability, services provided, patient access, physicians, and contractual capabilities. For instance, among these top 100 systems is Kaiser Permanente, a network of 37 hospitals, 611 medical offices, and almost 17,000 physicians across nine states and the District of Columbia. Under the Kaiser Permanente system, multiple aspects of patient care are integrated through shared electronic medical records, implementation of multi-disciplinary care pathways, and shared financial risk among providers. 18, [22] [23] [24] Kaiser Permanente offers a variety of different group and individual plans, including coverage for patients eligible for Medicare parts A and B.
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Study Population
Our study included all patients older than 65 years who underwent major surgical resection for a single cancer diagnosis from 2011 to 2013. Cancer diagnoses included malignancies of the prostate, bladder, esophagus, lung, liver, colon, pancreas, kidney, and ovary. We identified these patients using the International Classification of Diseases, Ninth Revision (ICD-9) diagnosis and procedure codes from MEDPAR to confirm the cancer surgery of interest for each patient, as per previously described methods. 26 We identified the hospital that provided surgical care from MEDPAR based on where claims pertaining to the cancer surgery originated. Patients were excluded if they did not have full enrollment data, complete claims, or Medicare parts A and B coverage. Also, we excluded patients who did not receive surgical resection for their cancers and those who underwent surgery for two or more malignancies less than 180 days apart. This study was deemed exempt from review by the Institutional Research Board at our institution.
Determining Perioperative Outcomes
Our outcomes of interest included rates of 30-day readmission and mortality, perioperative complications, and prolonged hospital stay. Perioperative complications were defined using previously established methods and identified based on whether specific claims were present for gastrointestinal, cardiac, renal, genitourinary, infectious, neurologic, wound, and technical complications occurring within 30 days after surgery. [26] [27] [28] Prolonged hospital stay was defined as a stay exceeding the 90th percentile length of hospitalization for each cancer-specific subgroup. We also investigated failure to rescue as a secondary outcome in our study. Failure to rescue is defined per previous studies as postoperative mortality after at least one complication.
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Statistical Analysis
We first performed a univariate analysis to investigate unadjusted associations between hospital IDS affiliation and development of the perioperative outcomes of interest for all cancer surgery patients in our study cohort. Next, we stratified our analysis by individual cancer type to compare cancer-specific rates of each perioperative outcome between patients receiving care at IDS-affiliated hospitals and those receiving care at non-IDS hospitals.
After our stratified analysis, we performed a multivariable logistic regression using generalized estimating equations to compare our primary and secondary study outcomes, with IDS affiliation as the primary exposure variable, while adjusting for both patient-and hospitallevel characteristics and the effect of patient clustering within hospitals. The patient-level factors included age, sex, race, cancer surgery type, and comorbidities defined via the Elixhauser Comorbidity Index. 31 The hospital-level characteristics included geographic region, profit status, rural versus urban status, total annual volume of cancer surgeries, bed availability, and teaching status.
Sensitivity Analysis
Due to potential variations in the surgical volume-outcome relationship among cancer types, we calculated Pearson's correlation coefficient between total hospital volume and hospital cancer-specific volumes. All analyses were performed using SAS (SAS, Cary, NC, USA) and STATA 14/SE (STATA, College Station, TX, USA), with statistical significance indicated at the 5% level.
RESULTS
We identified a total of 380,053 Medicare beneficiaries who underwent major cancer resection from 2011 through 2013. Of these patients, 37.7% had surgery at a hospital affiliated with one of the top 100 IDSs, representing 39.2% of prostate, 35.9% of bladder, 41.1% of esophageal, 41.2% of pancreatic, 37.3% of lung, 42.5% of liver, 36.9% of kidney, 36.8% of colorectal, and 41.6% of ovarian cancer cases. Of the 100 IDSs listed in Becker's Hospital Review, 92 were represented in our cohort, and 31% of the hospitals (817 of 2635) in our cohort were observed to be affiliated with an IDS. Table 1 compares the characteristics of the patients treated at IDS hospitals and those treated at non-IDS hospitals. Although differences in patient age, race, cancer type, and comorbidities are significant for both IDS and non-IDS hospitals, these differences are less than 1% in magnitude. No significant difference in gender distribution was observed between IDS and non-IDS hospitals. Table 2 compares the differences in hospital characteristics between IDS-and non-IDS-affiliated hospitals. Generally, IDS hospitals tend to be nonprofit and located in the Midwest (32%) and Southern (30.8%) regions. The IDS hospitals also were observed to have higher surgical volumes (176 vs 130 annual cases; p \ 0.001) and a greater number of hospital beds (262 vs 233 beds; p = 0.0013) than the non-IDS hospitals.
We observed small differences in unadjusted outcomes between patients treated at IDS hospitals and those treated at non-IDS hospitals. Specifically, the IDS hospitals had fewer 30-day mortalities (3.2% vs 3.5%; p \ 0.001) and prolonged stays (9.2% vs 9.9%; p \ 0.001) than the non-IDS hospitals (Table 3) . No significant differences between non-IDS and IDS hospitals in readmission rates (12.4% vs 12.3%; p = 0.33) or perioperative complication rates (43.6% vs 43.3%; p = 0.13) were observed.
Cancer-stratified rates of adverse perioperative outcomes between integrated and non-integrated hospitals are shown in Fig. 1 . Generally, we noted minor differences in 30-day mortality, readmissions, and prolonged hospital stay between IDS and non-IDS hospitals for some cancers, including prostate, kidney, and colorectal cancers. No significant differences in readmission rates between IDS and non-IDS hospitals were noted among any cancer strata. Additionally, no significant differences in readmissions, 30-day mortality, perioperative complications, or prolonged 
Secondary Outcomes
Unadjusted analysis initially showed lower rates of failure to rescue at IDS than at non-IDS hospitals (7.1% vs 7.8%; p \ 0.001). However, after adjustment for hospitaland patient-level risk factors, receiving care at an IDS hospital was not associated with failure to rescue (OR 0.97; 95% CI 0.92-1.02).
Sensitivity Analysis
Overall, we observed evidence of consistency in surgical volume across procedures, as demonstrated by strong correlations (r C 0.70) between overall hospital volume and cancer-specific volumes.
DISCUSSION
Outcomes for hospitals associated with highly integrated delivery systems did not differ from those for non-IDS hospitals with regard to readmission and surgical complication rates, and only minor differences were observed for 30-day mortality, failure to rescue, and prolonged hospital stay. When we stratified outcomes by cancer type, our results demonstrated slightly improved outcomes at IDSs for certain cancers. However, after accounting for differences in the patient population and hospital characteristics, the frequencies of these adverse perioperative outcomes were not significantly associated with integration. Overall, our collective findings suggest that local delivery system integration does not necessarily have an impact on perioperative outcomes in surgical oncology.
Our finding that hospital participation in a highly integrated health system does not independently affect perioperative outcomes for major cancer surgery is consistent with the findings of previous studies investigating the effect of integration on inpatient hospitalization and surgical outcomes. 17, 19, 26 Using pre-2008 claims data, investigators have reported no significant difference in operative mortality, postoperative complications, or readmissions for common, non-oncologic, inpatient surgical procedures between integrated and non-integrated hospitals, except for an 0.8% difference in readmissions for colectomy patients. 19 For hospital-based care of patients with complex medical conditions, researchers found no difference in readmissions, mortality, or hospital stay based on integration status for inpatient care of congestive heart failure. 17 In contrast, researchers have reported that specific delivery system characteristics, such as increased surgical volume, care transition coordination, and nationally implemented quality improvement programs, can improve outcomes in the post-hospitalization period. [32] [33] [34] [35] However, these programs and policies are not unique to integrated delivery systems and may also be observed in many nonintegrated, independent hospitals.
Our study had several limitations. First, we used a definition of health system integration based on criteria set by Becker's Hospital Review. This methodology limited our Readmissions, % Mortality, % Second, we studied short-term perioperative outcomes. However, IDSs may be better positioned to improve longterm outcomes, care of chronic conditions, and other quality measures such as preoperative imaging and adjuvant or neoadjuvant therapy due to their focus on coordination among multiple providers. 21, 36, 37 Nonetheless, reducing perioperative outcomes such as readmissions and mortality does require a degree of the coordination and inter-professional communication that is a central tenant of health system integration. 38, 39 Third, IDS leakage may have been a potential issue because patients who receive routine care from a non-IDS provider may enter and exit an IDS solely for their surgery. However, despite the possibility of IDS leakage, our focus on prevention of readmission, timely discharge, and recognition and management of postoperative complications also was dependent on successful care transition and coordination within the confines of an integrated hospital.
Finally, because this analysis was based on MEDPAR claims, our findings may not be generalizable to patients with private insurance or those covered under Medicare Advantage. Nonetheless, Medicare parts A and B currently provide coverage to one of the largest, most diverse patient populations in the United States, and results for this population carry wide implications for alternative models of reimbursement. 40, 41 Furthermore, older patients with more comorbidities may be more likely to benefit from care coordination and integration, so understanding its implications for this patient population has particular relevance.
Despite these limitations, our findings are relevant to multiple health care stakeholders that stand to benefit from improvements in complex inpatient care. For hospital administrators, we have shown that highly structured and extensive integration alone may not be sufficient to improve short-term surgical outcomes. Although health care integration has established benefits for primary and ambulatory care, evidence of specialist and surgeon engagement in integrated systems is lacking. Recent studies suggest wide variation in the participation of surgical specialists in accountable care organizations (ACOs) 42, 43 and poorly defined roles for surgeons within these types of organizations. 44 As such, improvements in the care of surgical patients may require additional quality improvement efforts tailored to the perioperative and inpatient settings.
Our findings also can aid policymakers in their efforts to create programs and legislation to improve outcomes in a cost-efficient manner. In particular, health care reform during the past decade has seen widespread adoption of ACOs to encourage integration among health systems to improve patient outcomes. 45, 46 However, based on the currently available data, such programs in isolation alone may have a limited impact on cancer surgery outcomes. 26, 47 Moving forward, additional research should focus on the effect of integration on long-term cancer outcomes, as well as on surgical-and oncologic-specific methods of care coordination such as pathway implementation and care transition programs. Using these data, stakeholders can continue to enhance the delivery of health care to promote efficient spending and improve outcomes for patients who require complex cancer care. 
